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                                  ABSTRACT 
 
Monoactylferrocene and diactylferrocene were successfully used to prepare [(
5
-
C5H5)Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C6H4-OH}] (3) and C5H5)Fe{(
5
-C5H4)C(CH3)=N-
N(H)C(O)-C5H4N}] (4) and [Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C6H4-OH}2] (5) and 
[Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C5H4N}2] (6) respectively. These new compounds have 
been characterized by FTIR, NMR spectroscopic methods.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of contents 
                                           
                  
Chapter-1                                  Introduction                                                    
1.1  Cyclopentadienyl Organomettalic Compounds                                             
1.2  Ferrocene And Its Redox Properties                                                              
1.3 Ferrocenyl-Schiff Base Organomettalic Compounds                                     
1.4 Ferrocenyl Peptide Conjugates As Anti Cancer Agents                                 
1.5 Ferrocenyl Based Compounds As Antimalarial Agents                                       
1.6 Ferrocene As Luminiscence Quencher                                                                     
1.7 Conclusion                                                                                                                
                                                   
    Chapter-2         Synthesis and characterization of ferrocenyl and 
                                            Cymantrenyl Schiff base compounds                                     
          2.1 
5
-C5H5 based Schiff base compounds                                                               
          2.2 Results and Discussion                                                                                                           
           
         2.3. Experimental Sections                                                                                         
             
         2. 3.1 General Procedures                                                                                           
         2.3.2 Synthesis of [(
5
-C5H5)Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-R}]  
               {R = C6H4-OH; C5H4N}                                                                                        
        2.3.3 Synthesis of [Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-R}2]       
                {R = C6H4-OH; C5H4N}                                                                                      
        2.3.4 Reaction of [Fe{(
5
-C5H4)COCH3}2] with isonicotino hydrazide                      
        2.3.5 Synthesis of [(CO)3Mn{(
5
-C5H4)C(CH3)=N-N(H)C(O)-R}] {C5H4N}           
        2.4Conclusion                                                                                                              
References                                                                                                                             
 
 
 
 
 
 
          Chapter 1 
                         INTRODUCTION 
 
 
 
 
 
 
 
1.1 CYCLOPENTADIENYL ORGANOMETALLIC COMPOUNDS 
Cyclopentadienyl, abbreviated as Cp
-
 has been the most important of all the polyenyl 
ligands as it is firmly bound to the metal and is generally neutral to nucleophilic reagents 
which signify its flexibility to be used as a stabilising ligand for many complexes.  It 
generally co-ordinates in the η5-mode and it can adopt rarely the η1-and η3-co-oridnation 
mode (Fig.1). 
[1] 
M  
Fig.1:
 η1 and η5 modes of cyclopentadienyl bonding 
In general, three categories of mononuclear cyclopentadienyl complexes of transition metals 
are known; Cp2M (metallocenes or sandwich compounds), Cp2MLx (bent metallocenes, x=1-
3; L= unidentate ligand like H, Cl, CO) and CpMLy (half sandwich or piano stool, y=1-4; 
unidentate ligand).  Some of unique characteristics of Cp have made it an important source of 
metallocene chemistry in various organometallic synthesis
[2]
. 
  Since the discovery of ferrocene
[3]
, cyclopentadienyls have been among the most 
important ligands in organo-transition metal chemistry because they form a wide range of 
stable complexes whose steric and electronic properties can easily be tailored by varying the 
ring substituents
[4]
.  A vast number of mono- and dicyclopentadienyl transition metal 
complexes have been reported in recent years, and over the past few years, Cp based 
transition metal compounds were being designed to serve the various purposes like molecular 
sensor, molecular ferromagnet, electrochemical agents, molecular switches, liquid crystal and 
drugs
[5-9]. The η5- cyclopentadienyl and related early transition metal derivatives have been 
marked as an important source to serve the purposes of structural, synthetic and catalytic 
organometallic chemistry.  They are useful compounds which have found applications as 
reagents in organic chemistry
[10]
, as soluble Zieglar-Natta catalysts and as a cancerostatic 
compounds
[11-15]
.  The Cp based transition metal compounds connect the link between 
organometallic chemistry to biology, medicine and molecular biotechnology
[16]
.  Recent 
research has been focussed to explore the chemistry of metal-metal interactions in ferrocenyl 
complexes as it can act as an important redox active unit undergoing oxidation to the 
ferrocenium ion
[17-24]
.  This has led to the use of ferrocene as a model for sensors and non-
M
 
 
linear optical films
[25,26]
.  The structure of ferrocene is as much vital as its characteristics 
(Fig.2).   
Fe
 
Fig.2: Structure of ferrocene 
Ferrocene contains two cyclopenatdiene rings pi-coordinated to Fe(II) atom.  The 
discovery of ferrocene was first reported by Pauson and Kealy in 1951.  The reaction was 
carried out between cyclopentadienyl magnesium bromide and ferric chloride to obtain a 
product fulvalene.  Later the sandwich structure of Cp2Fe was discovered by G. Wilkinson, 
R. B. Woodward and E. O. Fischer independently
[27]
.  The structure contains two Cp units in 
which all five carbon atom of a cyclopentadienyl ligand interacting with the metal centre.  
Ferrocene has an eclipsed configuration in the gas phase and is nearly eclipsed in the solid 
state.  The barrier to rotation between the two rings is only 4±1 kJ/mol and this allows the 
rings to have free rotation.  All the C-C bonds are of the same length and the iron is 
equidistant from all the Cp ring carbons.  Neutron diffraction has also shown that the 
hydrogen atoms on the Cp rings are tilted slightly towards the iron centre in ferrocene, 
presumably because this shift permits a better overlap of the Fe orbitals with the pi-orbitals of 
the Cp rings. In the recent years, ferrocene is widely applicable for the preparation of 
functional derivatives used in many areas like catalysis, material science, hydrometallurgy, 
biology and medicine.  Ferrocene is also the safest additive used so far as it does not cause 
any environmental pollution or health related hazardous
[28]
.  It is claimed that if used as fuel 
catalyst for rocket propellant, it can improve the combustion speed by 1-4 times, lower the 
temperature of exhaust pipes, and avoid infrared chase.  When used in fuel oils as diesel oil, 
heavy oil and light oil, it can eliminate smoke, save energy and reduce air pollution. 
Metallocenes, including ferrocene, are also known to have a wide range of biological 
applications.  Ferrocene has attracted particular attention due to its aromatic character, 
stability and low toxicity.  It can also be easily derivatized and the central iron atom is also 
easily oxidised from Fe(II) to Fe(III).  The medicinal application of ferrocene is currently an 
active area of research with many reports showing its activity in vivo and in vitro and its 
potential as an anti-tumour, anti-malarial and anti-fungal agent
[29]
.  Therefore, the astounding 
 
 
diversity of the chemistry demonstrated by this compound is unique in organometallic 
chemistry. 
1.2 FERROCENE AND ITS REDOX PROPERTIES: 
Ferrocene, also known as dicyclopentadienyl iron, has the primary chemical formula 
C10H10Fe with a characteristic orange colour at room temperature.   Ferrocene, a crystalline 
diamagnetic solid is considered as the most stable of all the metallocenes with 18 valence 
electrons and has a boiling point of 249
o
C, a melting point of 173-174
o
C. It sublimes readily 
and is stable to air or water, which makes purifying the products quite an easy task but can 
be, oxidized reversibly.   
The most important property of ferrocene is its redox property which has popularized 
this compound.  The electron transfer-reactive oxygen species-oxidative stress theory (ET-
ROS-OS) has been implicated in the mechanism of action of a wide variety of biologically 
active compounds, for example nitroaromatics and quinones.  Therefore, the development of 
drugs that enhance Reactive Oxygen Species (ROS) has increased in importance.  Also the 
fact that cancer tissue is known to be in a state of oxidative stress further increases the need 
for new drugs that can exploit this fact
[30]
.  Increasing the concentration of ROS may 
overwhelm the cancer cells but leave normal cells unaffected. Elevated levels of ROS are 
also known to induce apoptosis.  Current attention is given on increasing concentration of 
ROS to lethal levels in cells, interfering with anti-oxidant enzymes and the promotion of 
catalysts that enhance the toxicity of the ROS.   
The loss of an electron from a high energy, non-bonding orbital to yield the 
ferricenium cation, (Fc
+
Fc), is an important aspect of the chemistry of ferrocene and is 
often implicated in its cytotoxicity
[30]
 (Fig.3).  
Fe Fe
 
Fig.3: One electron oxidation of ferrocene to ferricenium ion. 
 
In biological systems ferrocene can be oxidised by hydrogen peroxide in the presence 
of horseradish peroxidise, found in the roots of horseradish, has been extensively studied. The 
hydroxyl radicals formed from Fc
+
 under physiological conditions are proposed to act as 
DNA damaging agents for biologically active ferrocene derivatives. The ferricenium cation 
 
 
has been shown to form charge transfer complexes with donor groups in proteins. The reverse 
reaction, (Fc
+
Fc), is known to proceed through oxidation of metalloproteins, in the 
presence of glutathione forming hydroxyl radicals and through oxidation of NADH to NAD
+
. 
The oxidation of NADH to NAD
+
 is a good indicator of the ferricenium cations capacity for 
interfering with biologically important, enzyme controlled electron transfer reactions.   
The redox status of a given biological system is vitally important as numerous 
processes in living cells are mediated by redox reactions.  For example, cellular respiration 
whereby ATP is formed involves a series of reactions including the reduction of NAD
+
 and 
oxygen and the oxidation of sugars.  Redox activation of otherwise inactive prodrugs coupled 
with further chemical modification e.g. hydrolysis, can lead to highly reactive electrophilic 
compounds.  A suitable bio-redox prodrug should have minimal toxicity to healthy cells, 
stability to metabolism in aerobic cells and suitable bioavailability and pharmacological 
properties. 
 
1.3 FERROCENYL-SCHIFF BASE ORGANOMETALLIC COMPOUNDS 
Over the last few years, several Schiff bases containing ferrocene groups have been 
prepared and their coordination behaviour studied by means of different physico–chemical 
measurements such as IR, NMR and electrochemical data and their structure was determined 
by single crystal X-ray diffractometric investigations.  In these studies, Mossbauer 
spectroscopy was also employed and revealed its important role for a better understanding of 
the properties of the prepared compounds
[31-43] 
(Fig. 4).   
Schiff base compounds are condensation products of arylamines and carbonyl 
compounds; these compounds are quite stable and represent versatile intermediates for 
preparation of a numbers of important compounds like arendiazonium nitrates, N-
arylarencarboxamides, corresponding amines and cyanoamines, β-lactams etc.  Incorporation 
of ferrocene moiety into Schiff bases imparts the chemical and physiochemical properties 
which are absent or little manifested in the parent substances.  Schiff bases and related 
analogues bearing ferrocenyl moieties have been widely synthesised and their properties and 
possible applications investigated
[44]
. 
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Fig.4- Ferrocenyl Schiff based compound 
 
The most recent research area, bio-organometallic chemistry is gaining a lot of 
interest in which the use of ferrocenyl-schiff base compounds is highly recommended.  
Bioorganometallic chemistry is a field devoted to the synthesis and study of organometallic 
species of biological and medical interest.  Keeping in view the reported biological studies, 
simple schiff bases, schiff bases, with ferrocene addition and their reactants were investigated 
for their biological activities towards antitumor, antioxidant and DNA protecting effects.  In a 
recent study crown gall tumor inhibition assay is used for verification of anticancerous 
activity of some of the ferrocenyl schiff bases.  The purpose of DPPH scavenging assay was 
to evaluate the antioxidative potential of test samples.  While in vitro OH radical induced 
DNA damage system served to evaluate DNA protection in oxidative stress.  Lanthanide ion 
complexes with ferrocenyl-schiff base ligands have proven to be very important in the area of 
photobiology and ligand to metal energy transfer studies
[45]
.  
A series of ferrocenyl carboxylic acid has been prepared and condensed, via their acid 
chlorides or in the presence of N,N’-dicyclohexylcarbodimide, with both 6-aminopenicillanic 
acid and 7-aminocephalosporanic acid.  Almost all of the Ferrocenyl-penicillin (Fig.5) and 
cephalosporins (Fig.6) exhibited anti-biotic activity, some being highly active, with others 
proved to be potent β-lactamase inhibitors. 
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Fig.5: Ferrocenyl-penicillin 
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Fig.6: Ferrocenyl-cephalosporins 
 
1.4 FERROCENYL PEPTIDE CONJUGATES AS ANTI-CANCER AGENTS 
Standard peptide coupling procedures were used by Kelly et al to prepare a series of 
N-(ferrocenylmethyl)fluorobenzene-carboxamide derivatives as shown in Fig.7. The 
inclusion of fluorine is a recognized strategy in the development of various drug types
[46]
. 
This series was screened against ER(+) MDA-MB-435-S-F breast cancer cells.  This 
particular compound was found to be the most active with an IC50 value of between 11 and 
14 μM. As the concentration of compound was increased, cytotoxicity increased, indicating a 
dose dependent relationship. 
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Fig.7: Structure of N-(ferrocenylmethyl)fluorobenzene-carboxamide 
 
N-(ferrocenyl) benzoyl dipeptide esters have also been shown to be highly active in vitro
[47-
49]
. N{ortho-(ferrocenyl)-benzoyl}-glycine ethyl ester was initially tested for its in vitro anti-
proliferative activity towards lung cancer cells (H1299 and H1299 carboplatin resistant 
variant) which was found to be cytotoxic whereas the starting material, ortho-ferrocenyl ethyl 
 
 
benzoate, was completely inactive.  Therefore other derivatives were evaluated for their 
anticancer activity against lung cancer cells.  This compound was found to be cytotoxic and 
had an IC50 value of 48μM, whereas the starting material, ortho-ferrocenyl ethyl benzoate, 
was completely inactive against this cell line. The dipeptide derivative N-{ortho-(ferrocenyl)- 
benzoyl}-glycine-glycine ethyl ester was shown to have an IC50 value of approximately 20 
μM, while N-{ortho-(ferrocenyl)-benzoyl}-glycine-L-alanine ethyl ester (Fig.8) had an IC50 
value of 5.3 μM. The activity of these compounds is possibly due to their low redox 
potentials and their ability to form reactive oxygenated species (ROS) under physiological 
conditions. The activity of compound N-{ortho-(ferrocenyl)-benzoyl}-glycine-L-alanine 
ethyl ester is not solely due to ferrocene so it is plausible that the peptide chain is involved in 
a secondary mode of action. The lipophilic ferrocene group may anchor to the cell membrane 
and the peptide chain may block the opening of channels in the cell membrane leading to cell 
death
[50]
. 
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Fig.8: Structure of N-{ortho-(ferrocenyl)-benzoyl}-glycine-L-alanine ethyl ester 
 
1.5 FERROCENYL BASED COMPOUNDS AS ANTIMALARIAL AGENTS 
Malaria is a mosquito-borne disease of humans and other animals caused 
by eukaryotic protists of the genus Plasmodium, of which Plasmodium falciform is the most 
dangerous and accounts 90% of all deaths from malaria.  Malaria is a tropical disease and It is 
estimated that the number of deaths ranges from 1.5 to 2.7 million per annum
[51]
, the majority 
 
 
of these deaths occur in Africa and South East Asia. Quinine, prepared from cinchona bark, 
was the first antimalarial drug developed and the synthetic anti-malarials like choloroquine, 
primaquine, proguanil, pyrimethamine and mefloquine were developed later.  Chloroquine 
(CQ) (Fig.9), introduced for chemotherapy of malaria in 1943, is the most widely used drug. 
Inspired by the work of Jaouen in cancer chemotherapy, an attempt has been made to 
use a bio-organometallic strategy to generate an antimalarial class of compounds having 
ferrocene.  Ferroquine
[52]
 (Fig.10), a ferrocene analogue of chloroquine, has recently entered 
initial clinical trials and is found to be more active than chloroquine against Plasmodium 
Falciparum which is resistant to chloroquine.  Ferroquine (FQ) satisfies the ‘Lipinski’s rule of 
5’which orally active drugs must follow to be efficient. 
 
 
 
 
 
Fig.9: Structure of Chloroquine 
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NCl  
Fig.10: Structure of Ferroquine 
The mechanism of action of ferroquine was found to be similar to that of 
chloroquine
[53]
.  In red blood cells the drug becomes protonated, subsequently it binds to 
heme to form a drug-heme complex that is highly toxic to the cell.  Ferroquine activity 
against chloroquine resistant parasites is attributed to an increase in lipophilicity and 
differences in electronic and geometric structure.  The continuing biological success of FQ 
means that this avenue of research will remain open for a long time
[54]
. 
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1.6 FERROCENE AS A LUMINESCENCE QUENCHER 
 
The photochemical behaviour of ferrocene and its derivative has also been 
investigated
[55]
.  Although they often are photochemically inert, ferrocene and ferrocenyl 
derivatives may undergo chemical modifications in the presence of light, or may be used as 
excited state quenchers or photosensitizers, that is as catalysts of photochemical reactions.  It 
has been seen that some properties of ferrocenyl compounds, which are profitably used in 
photochemistry, also are of major interest for photophysics.  Ferrocene has been widely used 
as a luminescence quencher in intermolecular processes taking place in solution.  From a 
fundamental viewpoint, these quenching studies mainly allowed the nature of the excited 
states to be characterized.  Luminescence quenching led to numerous applications in the areas 
of analytical chemistry, molecular organized systems and biology.  Recently, new compounds 
have appeared, in which the ferrocenyl derivative is covalently linked to a luminescent 
molecule.  Interaction is, therefore, of the intramolecular type.  The phosphorescence 
spectrum of ferrocene, which should correspond to the radiative deactivation of the excited 
triplet state, has been studied in details.  As early as 1961, Scott and Becker reported that 
ferrocene was phosphorescent when excited to the singlet excited states
[56]
.  The spectrum 
displayed a wide band centered at 20 000 cm−1.  After this many research groups reported 
different reports on phosphorescence spectrum of ferrocene.  Finally, Müller-Goldegg and 
Voigtländer attributed these phosphorescence reports from the early literature to photolysis 
products of ferrocene
[57]
.  It is now generally accepted that, unlike other metallocenes, 
ferrocene is not phosphorescent at all. 
The ferrocenyl derivative and the fluorescent molecule were brought together in 
solution.  Quenching was, therefore, of the intermolecular type.  Recently, some new 
compounds have appeared in which the ferrocenyl derivative is covalently linked to a 
luminescent moiety as shown in fig.10.  Luminescence quenching, if any, is then achieved 
intramolecularly.  Applications range from artificial photosynthesis aiming at light energy 
storage, to the design of photodiodes, potentially useful for molecular electronics. 
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Fig.10: Ferrocene linked to the luminescent moeity 
 
 
 
 
1.7 CONCLUSION 
 
The use of organometallic compounds for targeted medical purposes is a flourishing 
area of research.  Biologically active ferrocene derivatives can be classified into two groups, 
namely novel ferrocene compounds that exert a biological effect and ferrocene analogues of 
known drugs that have been prepared in order to overcome the problem of resistance.  
Numerous other applications can also be expected to emerge at the frontiers of 
biology and photophysics.  For example, ferrocene can be incorporated into amino acids and 
these could be used as building blocks in modified peptides, which can also bear 
photosensitizing chromophores and electron acceptors.  Such peptides could be potentially 
useful for photo harvesting.  Finally, since ferrocene can be introduced in a molecule without 
destroying the fluorescence properties, the door is now open on a new generation of 
compounds, both photo- and electrochemically active. 
The well established redox properties of ferrocene have been utilized in preparing 
various electrochemical sensors, and this redox activity has been strongly associated with 
the biological activity of ferrocenyl complexes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Synthesis and characterization of 
ferrocenyl and cymantrenyl Schiff 
base compounds 
 
 
 
 
 
 
 
 
 
 
 
2.1 
5
-C5H5 based Schiff base compounds 
Recently the research field of bioorganometallic chemistry is increasingly drawing 
much interest due to their distinctive properties and features concerning both organometallic 
and coordination chemistry 
[58]
.  The use of ferrocenyl derivatives as bioactive molecule has 
been growing very rapidly, and several reports shows that a large number of ferrocenyl 
compounds display interesting cytotoxic, anti tumor, anti malarial, anti-fungal and DNA 
cleaving activities 
[59-62]
.  A large part of the research is concentrated on the synthesis of 
conjugates of peptides and peptide nucleic acids with organometallic fragments.  However, 
investigation of bioactivity in organometallic compounds has been most extensively 
concentrated on ferrocene containing derivatives.  In recent years some Cp based half 
sandwich compounds have been studied to some extent for their interesting biological and 
labeling properties.  Several metallo carbonyl N-hydroxysuccinimide esters, for example 
rhenium based N-hydroxysuccinimide ester (Fig.11) were synthesized and characterized by 
classical spectroscopic methods and labelling of several proteins was achieved with these 
complexes 
[63]
. 
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Fig.11:  Rhenium based N-hydroxysuccinimide ester 
 
Substantially less study has been carried out with cymantrene based compounds and 
on their biological properties, in spite of their stability and easy attachment to bioactive 
molecules.  Very recently, cymantrene based carboxylic acid derivatives were introduced to 
peptides for IR labeling studies 
[64] 
(Fig.12). 
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Fig.12: Example of a cymantrene based carboxylic acid derivatives 
 
  To explore the variety of biologically active organometallic compounds the synthesis 
and characterization of some ferrocenyl and cymantrenyl organometallic compounds have 
been carried out and their redox and biological properties were investigated.   
 
2.2 Results and Discussion: 
 
 Room temperature reaction of an ethanol solution of salicyloyl hydrazide or 
isonicotino-hydrazide with monoacetyl ferrocene (1) for 3 hours gave an orange colored 
compounds [(
5
-C5H5)Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C6H4-OH}] (3) and [(
5
-
C5H5)Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C5H4N}] (4) respectively (scheme-1).   
O
CH3
Fe
X
O
NHNH2
R
CH3
N N
H
O
X
R
(3)   R = OH, X = H
(4)   R = H, X = N
Fe
EtOH
RT
(1)
 
Scheme-1 
Pure compounds were isotaled by preparative TLC for spectroscopic characterization.  
Similar reaction of 1,1’-diacetyl ferrocene (2) with two equivalents of salicyloyl hydrazide 
and isonicotino-hydrazide led to the isolation of orange compounds [Fe{(
5
-
 
 
C5H4)C(CH3)=N-N(H)C(O)-C6H4-OH}2] (5) and [Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-
C5H4N}2] (6) respectively (scheme-2). 
O
CH3
O
CH3
Fe
X
O
NH NH2
R
EtOH
RT
Fe
CH3
N N
H
O
X
R
N
N
HCH3
O
X
R
(6): R = H, X = N
(5): R = OH, X = CH
X = N, R = H
X = CH, R = OH
(2)
Scheme-2 
Infrared spectra for compound 3 and 5 as KBr pellet shows peaks at 1627cm
-1
,1607 
cm
-1
,1635 cm
-1
,1607 cm
-1
 corresponding to C=N and C=O groups respectively.  Presence of 
ferrocenyl Cp protons has been confirmed by 
1
H NMR spectral data at 4.1- 4.3 along with 
NH, OH and methyl protons at  11.14-  11.84 and  2.23 respectively.  Although, the 
synthesis of compound 3 and 5 have been reported earlier in thermal reaction condition, we 
have been able to synthesise both the compounds by reaction at room temperature condition.  
Similarly Infrared spectra for compound 4 as KBr pellet shows peaks at 1578 cm
-1
 and 1600 
cm
-1
 corresponding to C=N and C=O groups respectively.  Presence of ferrocenyl Cp protons 
has been confirmed by 
1
H NMR spectral data at 4.1- 4.3 along with NH and methyl 
protons at 10.93 and  2.30 respectively.  The IR and NMR spectral characterization reveals 
the presence of two hydrazone unit attached to each of the ferrocenyl Cp units. 
    
2.3. Experimental Sections 
2.3.1 General Procedures 
 All reactions and manipulations were carried out under an inert atmosphere of dry, 
pre-purified argon using standard schlenk line techniques.  Solvents were purified, dried and 
distilled under argon atmosphere prior to use.  Infrared spectra were recorded on a Perkin 
Elmer Spectrum RX-I spectrometer as KBr pellet and NMR spectra on a 400 MHz Bruker 
spectrometer in CDCl3.  Elemental analyses were performed on a Vario El Cube analyser.  
TLC plates (20x20 cm, Silica gel 60 F254) were purchased from Merck.  [(
5
-C5H5)Fe(
5
-
 
 
C5H4COCH3)], [Fe(
5
-C5H4COCH3)2], [(CO)3Mn(
5
-C5H4COCH3)], [H2NN(H)C(O)-R], (R 
= -C6H4-OH, C6H4N) were prepared by following reported procedures. 
2.3.2 Synthesis of [(
5
-C5H5)Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-R}] {R = C6H4-OH (3); 
C5H4N (4)} 
In a typical reaction, salicyloyl hydrazide or isonicotino hydrazide was taken in a two 
necked round bottomed flask and 10 ml of ethanol solvent was added.  To the reaction 
mixture 0.1 mmol of monoacetyl ferrocene and 1 drop of HCl or acetic acid was added at 
room temperature under stirring and inert atmosphere condition.  The reaction was continued 
for 3hrs or 12 hrs under nitrogen atmosphere.  After the reaction, the solution was filtered and 
the orange precipitate was washed with cold ethanol and vacuum dried.  The product was 
further purified by preparative TLC in 5% ethanol:pet ether solvent mixture. 
3: IR( CO, cm
-1
,CH2Cl2): 1607 (s), 1627 (s), 2922 (vs), 3446(br), 798(m).  
1
H NMR ( , 
CDCl3): 2.23 (s, 3H, CH3) 4.23 (s, 5H, 
5
-C5H5), 4.42 (t, 2H, 
5
-C5H4), 4.69 (t, 2H, 
5
-
C5H4), 6.96-7.01 (m, 2H, C6H4), 7.39-7.42 (t, 1H, C6H4), 7.95-7.97 (d, 1H, C6H4), 11.16 
(s,1H, OH), 11.84 (br, 1H, NH).   
4: IR( CO, cm
-1
,CH2Cl2):. 1600 (vs), 1578(vs), 3412 (br).  
1
H NMR ( , DMSO): 10.93 (s, 1H) 
8.82 (d, 2H, J=5.4 Hz) 7.86 (d, 2H, J=5.4 Hz), 4.78 (m, 2H), 4.49 (m, 2H) 4.29 (s, 5H), 2.30 
(s, 3H).  
2.3.3 Synthesis of [Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-R}2] {R = C6H4-OH (5); C5H4N 
(6)} 
 In a two necked flask, salicyloyl hydrazide or isonicotino hydrazide was taken and 
ethanol solvent was added.  The mixture was heated under nitrogen atmosphere to obtain a 
clear solution.  To the reaction mixture 0.1 mmol of diacetyl ferrocene and 1 drop of HCl was 
added at room temperature and stirring was continued for 3hrs.  After the reaction, the 
solution was filtered and the orange precipitate was washed with cold ethanol and vacuum 
dried.  The product was further purified by preparative TLC in 5% ethanol:pet ether solvent 
mixture. 
5: IR( CO, cm
-1
,CH2Cl2): 1607 (s), 1635 (s), 2930 (vs), 3277(br).  
1
H NMR ( , CDCl3): 2.23 
(s, 3H, CH3) 4.59 (s, 4H, 
5
-C5H5), 4.77 (s, 4H, 
5
-C5H5), 6.77-6.89 (m, 4H, C6H4), 7.25-7.29 
(t, 2H, C6H4), 7.90-7.92 (d, 2H, C6H4), 11.14 (s, 2H, OH), 11.59 (br, 2H, NH).   
 
 
 
2.4. CONCLUSION 
 Monoactylferrocene and diactylferrocene has been synthesized and characterized by 
FTIR and NMR spectroscopy.  Monoactylferrocene was successfully used to prepare [(
5
-
C5H5)Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C6H4-OH}] and C5H5)Fe{(
5
-C5H4)C(CH3)=N-
N(H)C(O)-C5H4N}] compounds.  Similarly diactylferrocene was used to prepare [Fe{(
5
-
C5H4)C(CH3)=N-N(H)C(O)-C6H4-OH}2] and [Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C5H4N}2] 
compounds.  The compound,[(
5
-C5H4)COCH3Mn(CO)3] was reacted with isonicotino 
hydrazide to obtain [(CO)3Mn{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C6H4N}] .  These compounds 
have been characterized by FTIR, NMR and the biological and electrochemical studies are 
under investigation. 
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ANNEXURE 
 
 
IR Spectra of [(
5
-C5H5)Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C6H4-OH}] (3) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
79.2
85
90
95
100
105
110
115
117.8
cm-1
%T 
3853.46
3748.24
3673.71
3649.18
3446.71
2922.10
2851.79
2668.44
2578.32
1652.96
1627.37
1607.04
1542.39
1491.97
1457.23
1384.91
1310.69
1238.05
1158.97
1126.42
1105.60
1000.59
916.67
823.22
755.24
646.45
532.16
484.00
 
 
 
 
IR Spectra of [Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C6H4-OH}2] (5) 
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IR Spectra of [(
5
-C5H5)Fe{(
5
-C5H4)C(CH3)=N-N(H)C(O)-C5H4N}] (4) 
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